Selank

Selank is a compound originally produced in Russia, with the goal of treating anxiety and potentially even improving certain cognitive functions, such as learning and memory. However, the actual research behind this drug is still in an extremely early stage, and most of the claimed benefits have not been confirmed or validated by independent studies in healthy human users.

Developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Selank peptide is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Selank peptide, as well as a related peptide compound, Semax, have been found to inhibit enzymes involved in the degradation of enkephalins and other endogenous regulatory peptides. It has also been found to affect the activity of carboxypeptidase H and phenylmethylsulfonylfluoride-inhibited carboxypeptidase. For more research information on this peptide, please visit the following Wikipedia article.

*Vial top color may vary.